| |
| |
SPOT ON
|
|
Sitagliptin and TECOS: how a negative trial becomes positive
|
| |
| |
THERAPY FROM A CRITICAL VIEWPOINT
|
|
Heparin bridging in anticoagulation with coumarins
|
| |
| |
NEW ON THE MARKET
|
| |
MAO-B inhibitor safinamide (XADAGO) in PARKINSON's disease
Antidepressant vortioxetine (BRINTELLIX)
Ivermectin cream (SOOLANTRA) for rosacea
|
| |
| |
a-t IN BRIEF
|
| |
New instructions on the practical application of adrenaline auto-injectors
Diabetes research dominated by a small group of authors with conflicts of interest
Independent patient information soon by a service provider for health insurance funds and pharmaceutical industry?
|
| |
| |
CURRENT ADR NETWORK REPORT
|
 |
Pancreatitis with roflumilast (DAXAS)
|
| |
| |
e a-t IN INTERNET
|
| |
Adverse drug reaction missing from product information: sepsis with vemurafenib (ZELBORAF)
|
| |